Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: An observational cohort study
- 31 July 2010
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 89 (1), 46-51
- https://doi.org/10.1016/j.diabres.2010.03.015
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Insulin Glargine Safety in PregnancyDiabetes Care, 2009
- Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology GroupDiabetologia, 2009
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort studyDiabetologia, 2009
- Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabeticsThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic PatientsDiabetes, 2008
- Insulin AnaloguesNew England Journal of Medicine, 2005
- Intermediate metabolism in normal pregnancy and in gestational diabetesDiabetes/Metabolism Research and Reviews, 2003
- Evaluation of the Reproductive Toxicity and Embryotoxicity of Insulin Glargine (LANTUS) in Rats and RabbitsInternational Journal of Toxicology, 2002
- Pregnancy outcomes in the Diabetes Control and Complications TrialAmerican Journal of Obstetrics and Gynecology, 1996
- Glucose intolerance as a predictor of hypertension in pregnancy.Hypertension, 1994